European Biotechnology Magazine Spring 2022 | Special: Euro BioFairs Compass

EuroBioFairs Compass o Brazhyk -Elfranckito - Freepik.com

Spring 2022

SPECIAL

EURO BIOFAIRS COMPASS

European Biotechnology | Winter Edition | Vol. 20 | 2021

28 – 30 March 2022 Basel Switzerland

BIO-Europe Spring BIO-EUROPE SPRING Reconnecting and facilitating global partnerships in the life sciences, the business partnering conference BIO-Europe Spring 2022 will take place as a hybrid event from 28 to 30 March 2022 in Basel, Switzerland and from 4 to 6 April 2022 in a digital format.

It’s time once again to network and facilitate partnerships face-to-face at the premier springtime event for the life science industry. BIO-Europe Spring ® 2022 will be held March 28–30 in Basel, Switzerland.

Over the last year, we launched this new way of par tnering in the digital world and discovered its effectiveness in bringing the international life science community together to partner from any where in the world. That’s why our refreshed event approach will offer you two ways to attend. First, our All-Access Pass will allow you to attend the event on March 28 –30 and participate in virtual one-to-one meet-

› QUICK FACTS Registration Please visit bioeuropespring.com

ings on April 4–6, in addition to all ondemand content before and after the event. Second, our Digital Access Pass will allow you to participate in virtual one-to-one meetings and digital live networking sessions, April 4–6, and access on-demand content before and after the event. By marrying the best of the past with the new present, attendees can choose to partner onsite or digitally from home – gaining an equally valuable experience.

This event is expected to bring together over 2,500 leading executives from biotechnology, pharmaceutical and finance companies from around the world who will engage in 15,000+ partnering meetings.

With ONE login, partneringONE®, will allow delegates to experience the entire event from anywhere, including one-toone meetings and conference activities.

Whether you toast to building partnerships face-to-face or screen-to-screen come next spring, join your peers in life science for a global dealmaking event L like no other.

Come to Basel BIO-Europe® Spring is a key strategy for global biotech, pharma and investor s who attend in search of new collaboration par tners and deal opportunities and we are thrilled to be back face-to-face for its sixteenth annual edition.

We are excited to be returning to face-to-face events in 2022 with our new ‘smar t’ event format that embraces advantages of the digital delivery and melts them together with live people interaction at the event. This will make the event more effi cient than ever before. Come join us!

BIO-Europe ® Spring will bring together a wide variety of companies to present their licensing opportunities directly to potential partners, resulting in alliances that literally change the world. Partnering will also feature instant scheduling of all meetings mutually agreed to, so delegates can plan for their meetings much earlier in the process. Program content, led by respected industr y experts, includes business development, therapeutic areas, digital health, and start-up innovations available live and on-demand.

We hope to see you in Basel and online!

Pam Putz Managing Director Europe EBD Group

Pictures: EBD Group

52

DUST OFF YOUR PASSPORT, IN-PERSON EVENTS ARE BACK!

MARCH 28–30, BASEL, SWITZERLAND

APRIL 4–6, DIGITAL PARTNER ING

2022

The sixteenth annual BIO-Europe Spring® 2022 conference will be held March 28–30 in Basel, Switzerland with digital partnering days April 4–6.

Produced by:

Supported by:

Learn more: bioeuropespring.com

EURO BIOFAIRS COMPASS

European Biotechnology | Winter Edition | Vol. 20 | 2021

6th AMR Conference Novel Antimicrobials & AMR Diagnostics

7-8 April 2022 Congress Centre Basel Switzerland

Meet live again AMR CONFERENCE 2022 During the 6th AMR Conference industry,

SMEs, investors, clinicians, policymakers and regulators will fi nally meet live again to discuss the current state of the fi ght against antimicrobial resistance (AMR). The agenda will cover R&D strategies, pull incentives and a start-up competition.

Being an established platform to connect relevant AMR stakeholders from industry, SMEs, fi nance, hospitals, science, and policy, the sixth AMR Conference will provide two days packed with 20 sessions on the most urgent topics the AMR community is currently dis-

› QUICK FACTS › Programme – 80+ high-level speakers in 20 sessions; pre-conference day & workshops › Partnering – 1-to-1 partnering among the 400+ participants › Innovation – Start-up competition, poster session and exhibition Further information: www.amr-conference.com

cussing: How did policymakers in Europe and the US take over their role in establishing most needed pull incentives? Which new initiatives have been started to further push forward innovations in antimicrobial therapies and diagnostics? What updates can be provided by existing investors, funds and accelerators? Which approaches investigators are developing to improve the effi ciency of preclinical models as well as clinical trial designs?

Perspective of SMEs The 2022 conference edition, hosted by BIOCOM in cooperation with the European SME organisation BEAM Alliance, will be the fi rst face-to-face meeting of the AMR community in Europe for more than two years. Together with other major stakeholders such as CARB-X, the IMI AMR accelerator, the AMR Action

Fund, the Novo Repair Impact Fund and others, the stakeholders will explore further strategies to improve conditions for companies developing novel antimicrobials or AMR diagnostics. A special focus of the event is targeted to the perspective of innovative SMEs, their R&D pipeline, requirements for regulation and policy frameworks.

Improving clinical R&D In addition, the conference will be a platform to discuss innovative strategies to improve preclinical R&D as well as clinical trial designs. Among the partners of the event will be the EU-funded IMI AMR accelerator which is organising its annual meeting as a pre-conference event on 6 April. During the conference, the accelerator will provide, among others, particular insights on UNITE4TB, a 7-year, €185m new project aimed at changing the paradigm of clinical TB drug development. In addition, the conference will highlight innovative strategies such as phage therapies, vaccines and monoclonal antibodies, AI-driven models and novel diagnostics. Among the further highlights will be a startup competition, hosted by the pharmabacked incubator INCATE. Founders are requested to apply until January 31, 2022. The Top Ten will qualify for a pitch during the conference.

L

Picture: BIOCOM AG; stock.adobe.com

54

April 7-8

2022 Congress Center Basel | Switzerland

6th AMR Conference Novel Antimicrobials & AMR Diagnostics The #AMRconference is the one-stop-shop for all AMR stakeholders from industry, SMEs, start-ups, big pharma, academia, clinics, regulatory bodies, investors and public authorities.

Join us in Basel to meet and exchange!

More than 400 delegates from 25+ countries

80+ high-level speakers in 20 sessions

Pre-conference workshops and satellite meetings

A variety of topics from R&D to financing, regulation & incentives

Poster session, exhibition and prescheduled 1-to-1 partnering meetings

SMEs, academics and governmental agencies benefit from discounted fees

Supporting Partners:

Media Partner:

European Biotechnology Net work

©SciePro - stock.adobe.com

amr-conference.com #AMRconference

Organisation: BIOCOM AG I Jacobsenweg 61 I 13509 Berlin Christin Hohmann I amr@biocom.de I Tel. +49 (0)30 264921-55

EURO BIOFAIRS COMPASS

European Biotechnology | Winter Edition | Vol. 20 | 2021

2 - 3 May, 2022 Congress Centre Basel, Switzerland

Big bizz in Swiss SWISS BIOTECH DAY One of the leading biotechnology conferences in

Europe is a fi xed date in the community’s calendar. In 2021, more than 850 life sciences colleagues celebrated a reunion at the fi rst face-toface event since the beginning of the COVID-19 pandemic.

Panel discussions on the continued counter of the COVID-19 pandemic, post-COVID-19 supply chains and drug manufacturing, and the latest trends in the biotech sector attracted biotech executives, international delegations and investors alike.

More than 40 exhibitors, 50 company presentations, and 800 p artner d i s c u s s i o n s c o n t r i b u t e d t o t h e lively atmosphere of this networking event.

Building on this great success – a third of the audience is international –the Swiss Biotech Day is further developing to a truly global networking day and will be extended to 1.5 days in 2022.

This prolongation gives room for more information, more discussion, more pitches, more networking, and more time to fi nd interesting partners for future projects.

The conference covers world-renowned research in life and data sci-

Come to Basel

Swiss biotechs attracted record investments of 3.4bn – three times more than in 2019 – and created 8% more jobs.

Reason enough to once again seek the dialogue with the 1,000+ Swiss biotech companies and their international partners at the Swiss Biotech Day. We look forward to welcoming you on 2-3 May 2022 in Basel.

GREETING With over 850 visitors, the Swiss Biotech Day 2021 celebrated a successful comeback as a live event and documented the impressive growth of the Swiss biotech industr y in the midst of the COVID-19 pandemic.

R&D inve s tment grew by 10% in 2020 to C HF 2 . 2 b n , a n d

Dr Michael Altorfer CEO Swiss Biotech Association

ences and successful translation of innovations and new developments on the whole added-value chain to effi cient manufacturing and production. It attracts biotech entrepreneurs, international investors, researchers, analysts, political decision-makers, and industry stakeholders alike.

The event’s organizers will set up an inspiring programme with thematically focused panel discussions, allowing more time to interact with speakers and for networking.

An emphasis will lie on opportunities and synergies offered by the close collaboration of pharmaceutical and biotechnology companies that has shown impressive results in the COVID-19 pandemic. The trends in research and development, production, data management, artificial intelligence, and innovative fi nancing – there will be a lot to discover in Basel in May L 2022.

› QUICK FACTS REGISTRATION www.swissbiotechday.ch Highlights › Swiss Biotech Success Stories Awards › Innovative biotech start-ups and SME biotech companies › Thematically focused panel discussions › one-to-one partnering meetings

Pictures: SBA

56

© Swiss Biotech Association

!

Save the date

SWISS BIOTECH DAY

2 & 3 May 2022 Congress Center Basel The Swiss biotech industry is not slowed down by the Covid pandemic - this was shown at the live Swiss Biotech Day 2021 after it had to be postponed in 2020. Together with our business associates and investors this networking conference has become a great place for innovation, research and the advancement of biotechnology. As one of the leading biotechnology conferences in Europe, the Swiss Biotech Day 2022 is further developing to a truly global networking day and extending to 1.5 days.

We hope to see you in Basel on 2 & 3 May 2022 in person again.

What you can expect: › Meet 850+ senior experts from the life science industry › 50+ exhibitors from across Europe › Delegations from various regions › General Assembly of the Swiss Biotech Association › Swiss Biotech Success Stories Awards › Innovative biotech start-ups and medium-sized biotech companies › Thematically focused panel discussions › Pre-scheduled one-to-one partnering meetings

Supporting partners:

Sign in on our website at www.swissbiotechday.ch and stay updated about any news.

Organized by:

Media partners:

European Biotechnology Net work

EURO BIOFAIRS COMPASS

European Biotechnology | Winter Edition | Vol. 20 | 2021

10 – 12 May 2022 Cologne, Germany hybrid event – on-site and online

Hunting results RENEWABLE MATERIALS The unique concept of the Renewable Material

Conference 2021 hit the mark: bio-based, CO2-based and recycled are the only alternatives to fossil-based chemicals and materials. In 2022, the conference will be held as a hybrid event in Cologne.

For the second time, nova-Institute presents numerous market highlights from bio- and CO2-based chemicals and materials as well as from chemical recycling: All material solutions based on renewable carbon. Together, there is sufficient potential to completely replace petrochemicals by 2050. To tackle climate change at its roots, all additional fossil carbon from the ground must be substituted with renewable alternatives.

Over the course of three days, participants will get a comprehensive over-

› QUICK FACTS Registration www.renewable-materials.eu/ registration/ Contact nova-Institut GmbH Mr. Dominik Vogt Phone: +49(0)2233-48-1449 Email: dominik.vogt@nova-institut.de www.renewable-materials.eu

view of the latest developments in the renewable material sector, with a focus on industry-ready solutions from a wide spectrum of sustainable raw materials and technologies.

The program includes a diverse range of bio-based materials such as bio-based polymers, plastics and biocomposites (fi rst and second generation, biowaste), CO 2-based materials (from fossil and biogenic point sources, atmosphere) as well as mechanically and chemically recycled materials.

The innovation award “Renewable Material of the Year” will showcase the vast spectrum of renewable materials.

The most outstanding winning products will be chosen by the conference participants and honoured at a festive awards ceremony.

On-site, the conference will be accompanied by a large exhibition where companies and institutes can showcase their recent developments. The supporting program, networking activities and many secluded spots at the location offer excellent opportunities to make contacts.

L

End of fossil carbon GREETINGS Readyto-use fossil-free sustainable material solutions with a low carbon footprint are in fast-growing demand. Innovative brand owners are keeping an eye out for such solutions, in particular those that will soon reach the mainstream.

In 2021, the new concept of the Renewable Materials Conference generated an outstanding response, which exceeded all expectations: 420 online participants witnessed a fi rework of innovations of non-fossil mate r ial.

60 speakers, 11 panel discussions, 500 public posts and 1,500 networking activities were proof of the lively exchange during the three conference days. In 2022, nova-Institute expects 400 participants on-site in Cologne and many more online.

Be part of the sustainable future of chemicals and materials: The Renewable Materials Conference will create new prospects and synergies by bringing together many cross-sectoral networking opportunities. Here, innovation and implementation connect.

We are looking forward to welcoming you in Cologne.

Michael Carus Managing Director, nova-Institute

Pictures: nova-Institut/vonPigage

58

nova Conferences To Grow Your Business Networks

The Best Market Reports Available: Bio- and CO2-based Polymers and Building Blocks as well as Chemical Recycling Bio-based Building Blocks and Polymers – Global Capacities, Production and Trends 2020 – 2025 Polymers

EPDM PP PE

PVC PMMA

Vinyl chloride Propylene

Unsaturated polyester resins

Methyl methacrylate

Polyurethanes

PEF MEG

Building blocks for UPR

Natural rubber Cellulose-based polymers

Ethylene

Aniline

2,5-FDCA

Building blocks for polyurethanes

Levulinic acid

Lignin-based polymers Naphtha

PFA Casein polymers

Furfural

Natural rubber Hemicellulose

5-HMF/5-CMF

MPG

PTF 1,3 Propanediol Fructose

Starch

Glycerol

11-AA

Glucose

DN5

PBAT

Adipic acid

Caprolactame HMDA

PBT

1,4-Butanediol

Succinic acid

DDDA

Sorbitol Lactic acid Isosorbide

3-HP Itaconic acid

Acrylic acid

PBS(x)

Lactide

PA

Superabsorbent polymers

Epoxy resins

ABS PHA

2 – 3 February 2022 Hybrid Event Cologne (Germany)

THF

Isobutanol

Lysine

Sebacic acid

SBR

p-Xylene

Plant oils

Castor oil

PTT

Terephthalic acid

Non-edible milk

NOPs

Fatty acids

FDME

Saccharose

Lignocellulose

Casein

ECH

PET

Ethanol Waste oils

Furfuryl alcohol

Starch-containing polymer compounds

APC

PLA

Authors: Pia Skoczinski, Michael Carus, Doris de Guzman, Harald Käb, Raj Chinthapalli, Jan Ravenstijn, Wolfgang Baltus and Achim Raschka January 2021 This and other reports on renewable carbon are available at www.renewable-carbon.eu/publications

renewable-carbon.eu/publications

cellulose-fibres.eu

More than 28,000 News on Bio-based and CO2-based Materials and Recycling

23 – 24 March 2022 Hybrid Event Cologne (Germany)

renewable-carbon.eu/news

co2-chemistry.eu

Science-Based Consultancy on Renewable Carbon for Chemicals and Materials RENEWABLE MATER IAL S CONFERENCE 2022

10-1210 – 12 May May 2022

What are future challenges, environmental benefits and successful strategies to substitute fossil carbon with biomass, direct CO2 utilisation and recycling? What are the most promising concepts and applications? We offer our unique understanding to support the transition of your business into a climate neutral future.

HybridHybrid Event Event

Cologne (Germany) renewable-materials.eu nova-institute.eu